FIELD: medicine.
SUBSTANCE: splenectomy is followed by determining its weight, carrying out morphometric measurements of an average area of the white pulp of the lymphoid organ in histological sections stained by haematoxylin and eosin. These values are taken into account to calculate a mass of the white pulp by formula: m=mspleen×D%/100%, wherein m is the mass of the white pulp (g), mspleen is the total mass of the spleen (g), D is the average area of the white pulp, %. If the calculated value is ≤8.4 g, the favourable prognosis for atrophic anaemia is established, and if the value is >8.4 g, the unfavourable prognosis of the disease is stated.
EFFECT: method enables the differentiated determination of the indications for treating patients with atrophic anaemia following splenectomy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MORPHOMETRIC ESTIMATION OF PROGNOSIS OF COURSE OF APLASTIC ANAEMIA AFTER SPLENECTOMY | 2014 |
|
RU2555355C1 |
METHOD FOR PREDICTION OF COURSE OF ATROPHIC ANAEMIA AFTER SPLENECTOMY ON INDEX OF RATIO OF MASS OF CD4+/CD8+T-LYMPHOCYTES SPLEEN | 2015 |
|
RU2594119C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ATROPHIC ANAEMIA AFTER SPLENECTOMY AFTER SPLENECTOMY BASED ON SPLEEN CD4+LYMPHOCYTES WEIGHT | 2016 |
|
RU2625036C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF POST-SPLENECTOMY IMMUNE THROMBOCYTOPENIA BY SPLENIC CD8+T-LYMPHOCYTE WEIGHT | 2014 |
|
RU2563284C1 |
METHOD FOR PREDICTION OF COURSE OF IMMUNE THROMBOCYTOPENIA FOLLOWING SPLENECTOMY BY WEIGHT OF CD4+ T-LYMPHOCYTES OF SPLEEN | 2015 |
|
RU2599021C1 |
METHOD FOR MORPHOMETRIC EVALUATION OF IMMUNE THROMBOCYTOPENIA COURSE PREDICTION AFTER SPLENECTOMY BASED ON SPLEEN CD4+/CD8+ T-LYMPHOCYTES WEIGHTS RATIO | 2016 |
|
RU2621627C1 |
METHOD OF INDUCING REMISSION IN PATIENTS SUFFERING ACQUIRED APLASTIC ANAEMIA | 2008 |
|
RU2412708C2 |
METHOD OF TREATING PATIENTS ILL WITH HYPOPLASTIC ANEMIA AFTER SPLENECTOMY | 0 |
|
SU843990A1 |
METHOD FOR PREPARATION OF BIOLOGICALLY ACTIVE SUBSTANCE, BASED ON VERMICULTURE | 2015 |
|
RU2606693C1 |
ANTITUMOR PREPARATION | 0 |
|
SU1453661A1 |
Authors
Dates
2014-12-10—Published
2013-05-21—Filed